The Drug Stock Higher on Asset Sale Rumors

TEVA stock has been on the rebound since November

Managing Editor
Dec 26, 2017 at 9:58 AM
facebook twitter linkedin

Drugmaker Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has had a rocky year, culminating in drastic cuts to its workforce and suspended dividend payments. Today, the stock is generating buzz amid reports that Israel's biggest pharmacy chain, Super-Pharm, is in talks to buy a Teva plant. Below, we take a closer look at TEVA stock.

Super-Pharm will reportedly pay between $17 - $23 million for the Ashdod-based plant, and would continue to employ the plant's 70 workers. The news has sent TEVA stock up 2.8% to trade at $19.26 this morning, on pace for its highest close since mid-September. Since falling to a 17-year low of $10.85 on Nov. 2, TEVA has tacked on 78%.

Despite the equity's solid rebound over the past couple of months, analysts remain pessimistic. Of the 23 brokerage firms covering the drug name, 20 rate TEVA shares a "hold" or worse. However, recent options buyers have been upping the bullish ante. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 50-day call/put volume ratio of 1.73 is higher than 87% of all other readings from the past year.


If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!



Special Offers from Schaeffer's Trading Partners